A Novel High-Throughput Technique for Identifying Monoclonal Antibodies Capable of Death Receptor Induced Apoptosis

Area of Science:

• Immunology
• Cancer Biology
• Drug Discovery

Background:

• Therapeutic antibodies targeting death receptors like DR4 and DR5 are effective in cancer treatment by inducing apoptosis.
• Developing agonistic antibodies for the Fas receptor has been challenging due to discrepancies between in vitro and in vivo antibody activity.

Purpose of the Study:

• To develop a novel high-throughput screening technique for identifying functional Fas receptor-targeting antibodies.
• To overcome the limitations of current in vitro methods that may lead to false negatives for potential therapeutic antibodies.

Main Methods:

• A new screening technique was developed involving artificial cross-linking of antibodies bound to the Fas receptor.
• Annexin-V and Propidium Iodide (PI) staining were used in conjunction with the cross-linking method.
• The method aims to identify antibodies capable of inducing apoptosis in vivo.

Main Results:

• The novel screening technique allows for the selection of antibodies with in vivo apoptotic potential.
• This method addresses the issue of antibodies that function in vivo but not in vitro.
• Potential therapeutic candidates previously dismissed as false negatives can now be identified.

Conclusions:

• The developed high-throughput screening method enhances the identification of Fas receptor-targeting antibodies.
• This approach improves the selection of antibodies that can effectively induce cancer cell apoptosis in vivo.
• The technique holds promise for advancing cancer immunotherapy development.